Loading...
•
Dec 31, 2019
Thermo Fisher Q4 2019 Earnings Report
Thermo Fisher Scientific reported strong Q4 2019 results, exceeding goals with excellent revenue and earnings growth.
Key Takeaways
Thermo Fisher Scientific reported a 5% increase in revenue to $6.83 billion for the fourth quarter of 2019. GAAP diluted EPS increased by 12% to $2.49, and adjusted EPS increased by 9% to $3.55. The company saw growth across all segments, driven by innovation and strategic acquisitions.
Revenue increased by 5% to $6.83 billion.
GAAP diluted EPS increased by 12% to $2.49.
Adjusted EPS increased by 9% to $3.55.
The company launched the Ion Torrent Genexus next-generation sequencing instrument.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
The company will provide 2020 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income